NCT05706012

Antithrombotic Management of Acute Mesenteric Ischaemia

Long-term Antithrombotic Management of Acute Mesenteric Ischaemia: Case-based Survey

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 51 (actual)
• Sponsor: Universitaire Ziekenhuizen KU Leuven · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Accepted

Summary

Guidelines on the acute and long-term pharmacological treatment of acute mesenteric ischaemia (AMI) recommend the use of thrombolytic, antiplatelet or anticoagulant therapy depending on the aetiology of AMI and the use of stenting but only few details are given on the choice of the drug, dose and duration of treatment. Besides, recommendations are mainly based on data on coronary, cerebral and other peripheral artery diseases and do also not take into account the altered drug absorption in patients with short bowel syndrome, in which AMI can result.This case-based survey will inform us on the current international clinical practice of long-term antithrombotic management of AMI.

Conditions

• Acute Mesenteric Ischemia
• Short Bowel Syndrome

Interventions

Type	Name	Description
OTHER	Survey	Online survey questioning the current clinical practice on long-term antithrombotic management of AMI in SBS patients

Timeline

• Start date: 2023-06-30
• Primary completion: 2024-02-29
• Completion: 2024-02-29
• First posted: 2023-01-31
• Last updated: 2024-05-09

Locations

1 site across 1 country: Belgium